Skye Bioscience, Inc. Current Liabilities
Skye Bioscience, Inc. (SKYE) had Current Liabilities of $11.53 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $11.53M.
- 2026-03-31: Liabilities, Current $10.40M.
- 2025-12-31: Liabilities, Current $8.21M.
- 2025-09-30: Liabilities, Current $8.37M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $11.53M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $10.40M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $8.21M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $8.37M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $8.31M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $5.32M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $4.34M 10-K · filed 2026-03-10 |
| 2024-09-30 | $5.62M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $14.32M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $15.80M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $13.90M 10-K · filed 2025-03-20 |
| 2023-09-30 | $13.72M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $9.82M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $9.37M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $12.12M 10-K · filed 2024-03-22 |
| 2022-09-30 | $6.15M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.24M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $4.18M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $3.91M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.50M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.55M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.38M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $787.20K 10-K · filed 2022-03-28 |
| 2020-09-30 | $1.21M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $2.16M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $1.67M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $970.82K 10-K · filed 2021-03-02 |
| 2019-09-30 | $14.26M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $11.10M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $28.71M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $15.94M 10-K · filed 2020-03-23 |
| 2018-09-30 | $11.32M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $10.29M 10-Q · filed 2018-08-10 |
| 2018-03-31 | $322.70K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $805.97K 10-K · filed 2019-03-14 |
| 2017-09-30 | $1.66M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $1.19M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $746.81K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $661.96K 10-K · filed 2018-03-19 |
| 2016-09-30 | $841.27K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $491.00K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $490.02K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $581.86K 10-K · filed 2017-03-10 |
| 2015-09-30 | $619.74K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.68M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $805.47K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $801.09K 10-K · filed 2016-03-21 |
| 2014-09-30 | $349.51K 10-Q · filed 2014-11-14 |
| 2014-07-31 | $43.48K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $49.35K 10-Q · filed 2014-06-05 |
| 2014-01-31 | $53.84K 10-Q · filed 2014-03-17 |
| 2013-12-31 | $182.15K 10-K · filed 2015-03-27 |
| 2013-10-31 | $62.32K 10-Q · filed 2014-09-15 |
| 2012-10-31 | $4.33K 10-K · filed 2014-01-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |